Your SlideShare is downloading. ×
0
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Infective Endocarditis
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Infective Endocarditis

1,589

Published on

Infective Endocarditis

Infective Endocarditis

Published in: Health & Medicine
0 Comments
4 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,589
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
0
Likes
4
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Infective Endocarditis http://crisbertcualteros.page.tl
  • 2. occurs when microorganisms (bacteria or fungi) colonize the endocardial surface of the heart Classified into four groups:1. Native Valve IE2. Prosthetic Valve IE3. Intravenous drug abuse (IVDA) IE4. Nosocomial IE
  • 3. Epidemiology The valves involved in IE:1. Mitral 28-45%2. Aortic 5-36%3. Both 0-35%4. Tricuspid 0-6%5. Pulmonary <1%
  • 4. Males > femalesMay occur at any age and increasingly common inelderlyMortality 20-30%
  • 5. Predisposing FactorsIV drug useCentral line Prosthetic valvePrevious IEDental procedureRheumatic heart disease
  • 6. High Risk1. Prosthetic cardiac valve2. Prior episodes of endocarditis3. Complex congenital cardiac defect4. Surgical systemic-pulmonary shunts5. Intravenous drug abuse6. Intravascular catheters
  • 7. Moderate Risk1. PDA, VSD, primum ASD2. Co-Aorta3. Bicuspid aortic valve4. Hypertrophic cardiomyopathy5. Acquired valvular dysfunction6. MVP with mitral regurgitation
  • 8. Low Risk1. Isolated secundum atrial septal defect2. ASD, VSD, or PDA > 6 months past repair3. “Innocent” heart murmur by auscultation in the pediatric population
  • 9. Pathophysiologya. Turbulent blood flow disrupts the endocardium making it “sticky”b. microorganisms infect the endocardial surface of the heart.c. Adherence of the organisms to the endocardial surfaced. Eventual invasion of the valvular leaflets
  • 10. EtiologyCommon bacteria in children Strep. viridans–50% Staph aureus–40% Strep fecalis, Grp D Streptococcus(Enterococci)
  • 11. Clinical Presentations High grade fever w/ chills SOB Arthralgias/myalgias Abdominal pain Pleuritic chestpain Backpain Anorexia Weight loss Fatigue
  • 12. SignsFeverHeart murmurpetechiae, subungal or“splinter”hemorrhagesClubbingSplenomegalyNeurologic changesJaneway lesionsRoth Spots
  • 13. Osler’s Nodes Janeway LesionsPainful ErythematousErythematousnodules BlanchingmaculesLocated on pulp of fingers and Nonpainfultoes Located in the palms and soles
  • 14. DiagnosticsBlood Cultures: Minimum of 3 takings3 separate venipuncture sites: 5 - 10mLDetects >95% of cases
  • 15. CBC Immunologic tests:ESR Increase inCRP gammaglobulinsUrinalysis Presence of cryoglobulin Low Complement levels(C3,C4) RF-positive
  • 16. Imaging CXR: multiple focal infiltrates and calcification of heart valves ECG: Look for evidence of ischemia, conduction delay and arrhythmias Echocardiography: diagnostic tool for culture negative cases
  • 17. Duke CriteriaClinical criteria for infective endocarditis requires:Two major criteria, orOne major and three minor criteria, orFive minor criteria
  • 18. ManagementGive for 2 – 6 weeks1.Penicillin - susceptible strep on native cardiac valves: 4weeks Pen G or Ceftriaxone + Gentamicin for 2wks2.Penicillin - resistant strep on native cardiac valves:Penicillin, ampicillin, or ceftriaxone for 4weeks +gentamicin for the first 2 weeks
  • 19. 5. Enterococcal infection on native valves - penicillin orampicillin + gentamicin for 4-6 weeks6. (MSSA) on native valves : Nafcillin or oxacillin for at least 6weeks + gentamicin for 3-5 days is optional7. (MRSA) on native valves: Vancomycin for at least 6 weekswith or without 3-5 days of gentamicin
  • 20. 8. MSSA infection on prosthetic valve : Nafcillin or Oxacillin +Rifampin for at least 6 weeks, in combination with Gentamicinfor 2 weeks.9. MRSA infection on prosthetic valve: Vancomycin + Rifampinfor at least 6 weeks, in combination with Gentamicin for 2weeks10. Gram Negative endocarditis due to HACEK: Ceftriaxone orAmpicillin plus Gentamicin for 4 weeks

×